Search
for
Sort by
Research 121–150 of 1000+
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Topical Calcipotriol Therapy for Mild-to-Moderate Alopecia Areata: A Retrospective Study.
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Bilateral Half-Head Comparison of 1% Anthralin Ointment in Children with Alopecia Areata
- Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2
- Congenital adrenal hyperplasia
- Extensive alopecia areata: Not necessarily recalcitrant to therapy!
- Response of alopecia areata of the beard to oral tofacitinib
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- BH06 (P075) A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- P075 A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata
- Evaluation of the Efficacy of Antihistamines in the combined therapy for Alopecia Areata
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Growth Factors and Microneedling in Alopecia Areata: A Narrative Review
- Study of effect of topical mometasone with intralesional platelet-rich plasma versus topical mometasone alone in the treatment of alopecia areata
- Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- A Study on the Role of Tofacitinib Among Patients Treated with Alopecia Areata
- Efficacy and safety of azathioprine in alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A retrospective cohort study of 90 patients
- Etiopathogenesis of Alopecia Areata
- Therapeutic Role of Pracchanna and Lepana in Indralupta (Alopecia Areata): A Case Study
- Evaluation of fractional carbon dioxide laser alone versus its combination with betamethasone valerate in treatment of alopecia areata, a clinical and dermoscopic study
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients